On August 29, 2018 Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, reported that senior management will participate in two upcoming healthcare investor conferences (Press release, Bellicum Pharmaceuticals, AUG 29, 2018, View Source [SID1234529127]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Details:

Event: Citi’s 13th Annual Biotech Conference
Date: Wednesday, September 5, 2018
Location: Boston, MA

Event: 2018 Wells Fargo Securities Healthcare Conference
Date/Time: Thursday, September 6, 2018 at 10:55 a.m. EDT
Location: Boston, MA

A live webcast of the presentation at Wells Fargo may be accessed from the News & Events section of the Bellicum website. An archived version of the webcast will be available for replay for at least two weeks following the event.